Home > Products > CD64 & HER2
> Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (IgG-Fv)
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (IgG-Fv) (CAT#: BSGV-128)
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-CD64 antibody variable domain is fused to the C terminal of an IgG of anti-HER2 antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can retarget neutrophils cells to tumor cells. It is designed for the research of Breast cancer; Gastric cancer; Prostate cacncer; Ovarian cancer; Solid tumors therapy.
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
There are currently no customer reviews or questions for Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (IgG-Fv) (BSGV-128). Click the button below to contact us or submit your feedback about this product.